Australian Society for Antimicrobials
 
  Become a Member

 

ASA Latest News

8 Mar 2019
Antimicrobials 2019 Travel Awards and Presentations
Antimicrobials 2019
 
Travel Awards
 
The ASA Committee congratulations the following ASA members for being awarded travel grants to attend Antimicrobials 2020.
 
ASA Poster Travel Award
 
Kyra Chua
Dorevitch Pathology and Austin Health, Victoria
Individual and Community Predictors of Ceftriaxone Resistant Escherichia coli Isolates, Victoria Australia
 
bioMerieux ASA Identifying Resistance Award
 
Frances Hurren
Austin Health Victoria 
Evaluation of the Carbapenem Inactivation Method (CIM) as a Predictor for Carbapenemase-producing Gram Negative Bacteria  
 
 
ASA Presentations
 
PDFs of many of the Antimicrobials 2019 presentations and posters are now available in the members area of the ASA website. 
7 Feb 2019
Antimicrobials 2019 Update: Thermo Fisher Lunch Symposium
Antimicrobials 2019
21 - 23 February 2019
Sheraton Grand Sydney Hyde Park, Sydney

www.antimicrobials2019.com

Thermo Fisher Lunch Symposium

During Antimicrobials 2019 the Thermo Fisher Lunch Symposium will be held on Saturday 23 February 2019.
 
"In an Era of Rapid Results, Why Broth Microdilution and the MIC Still Reign"
 
Speaker
Nathan Ledeboer
 
The MIC remains both an incredibly valuable tool for dosing antimicrobials and a potential source for laboratory induced medical errors.  With some reports suggesting considerable variation in the MIC based on laboratory methods, standardized testing is essential for accurate dosing.  This session will explore why BMD has remained unmatched in providing accurate MIC results, even as novel methods are being developed.
 
Antimicrobials 2019 Registration: www.antimicrobials2019.com
10 Jan 2019
Antimicrobials 2019 Update: Cepheid Lunch Symposium
Antimicrobials 2019
21 - 23 February 2019
Sheraton Grand Sydney Hyde Park, Sydney

www.antimicrobials2019.com

 
Cepheid Lunch Symposium
During Antimicrobials 2019 the Cepheid Lunch Symposium will be held on Friday 22 February 2019.
 
“Exploding myths about GeneXpert:  Fun Facts and Fiction”
 
Speaker:
Fred C. Tenover, Ph.D., D(ABMM), F(AAM), F(IDSA)
 
Dr. Tenover is Vice President of Scientific Affairs at Cepheid, Consulting Professor of Pathology at Stanford University School of Medicine, Adjunct Professor of Epidemiology in the Rollins School of Public Health at Emory University, and Consulting Professor of Biology at the University of Dayton.  He joined the Centers for Disease Control and Prevention in Atlanta in 1990 and served for 18 years as Associate Director for Laboratory Science in the Division of Healthcare Quality Promotion and then as Director of the Office of Antimicrobial Resistance for CDC. He joined Cepheid in California in 2008 where he focused his research studies on carbapenem resistance and the epidemiology of Staphylococcus aureus and Clostridiodes difficile. He is a Diplomate of the American Board of Medical Microbiology and a Fellow of both the American Academy of Microbiology and the Infectious Disease Society of America. He has authored over 350 peer-reviewed journal articles and has written or edited 11 books.

Antimicrobials 2019 Registration: www.antimicrobials2019.com
9 Jan 2019
Antimicrobials 2019 Update: MSD Lunch Symposium
Antimicrobials 2019
21 - 23 February 2019
Sheraton Grand Sydney Hyde Park, Sydney

www.antimicrobials2019.com
 
MSD Lunch Symposium
 
During Antimicrobials 2019 the MSD Lunch Symposium will be held on Thursday 21 February 2019.
 
“CMV+: What to Do With your Transplant Patient?”
•        Opening – Prof Monica Slavin (Chair)
•        Burden of CMV Infection and Disease in Allo-HSCT Setting – Dr Michelle Yong
•        Mechanism of Action of Anti-CMV Molecules – Prof Bill Rawlinson
•        Letermovir – Study Evidence of a Newly approved Terminase Inhibitor – Dr Emily Blyth
•        Q&A
 
For more than a century, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Today, MSD continues to be at the forefront of research to deliver innovative health solutions and advance the prevention and treatment of diseases that threaten people and animals around the world.
 
Important Antimicrobials 2019 Dates
Accommodation Booking Deadline: 11 January 2019

 
Antimicrobials 2019 Registration: www.antimicrobials2019.com
2 Jan 2019
Antimicrobials 2019: Early Bird Registration Deadline Friday 4 January 2019
Antimicrobials 2019
21 - 23 February 2019
Sheraton Grand Sydney Hyde Park, Sydney
www.antimicrobials2019.com
 
Early Bird Registration Deadline: Friday 4 2019
www.antimicrobials2019.com
 
 
Plenary Speaker Spotlight
 
Dr Romney Humphries
Dr Romney Humphries, Chief Scientific Officer at Accelerate Diagnostics, is highly regarded within the Microbiology and Infectious Diseases communities for her expertise, research, and contributions to the Clinical and Laboratory Standards Institute. She is particularly well known for her interest and publications in the area of antimicrobial susceptibility testing, new diagnostic technologies, and her work to address common issues faced by clinical microbiology laboratories.
 
Dr Romney Humphries  will be presenting the plenary "Antimicrobial Susceptibility Testing: Old Technologies for New Drugs and New Technologies for Old Drugs".  

Professor Jesús Rodriguez Baño
Professor Jesús Rodriguez Baño is a specialist in Internal Medicine; Expert degree in Epidemiology and Clinical Research; Professor of Medicine, Universidad de Sevilla. Head of Infectious Diseases Division at Hospital Universitario Virgen Macarena; Scientific coordinator of the Spanish Network for Research in Infectious Diseases (REIPI); and President, European Society of Clinical Microbiology and Infectious Diseases (ESCMID). He has authored over 280 peer-reviewed scientific papers.

Professor Rodgriguez Baño will be presenting the plenary "New Antimicrobials: Can we Avoid our Past Mistakes?". 
 
Professor Karin Thursky
Professor Karin Thursky is the Director of the National Centre for Antimicrobial Stewardship, a health services Centre for Research Excellence under the NHMRC, which is taking a one health approach to the challenges of optimising antimicrobial usage across both human and animal health. NCAS has a key role in the implementation of the National Antimicrobial Resistance strategy. 
 
Professor Karin Thursky will be presenting the plenary "Antimicrobial Sterwardship in Australia: Leaders or Laggareds?". 
 
For further information on the Antimicrobials 2019 meeting program: www.antimicrobials2019.com
21 Dec 2018
Antimicrobials 2019: ACSQHC Lunch Symposium
Antimicrobials 2019
21 - 23 February 2019
Sheraton Grand Sydney Hyde Park, Sydney
www.antimicrobials2019.com

Australian Commission on Safety and Quality in Healthcare (ACSQHC) Lunch Symposium

During Antimicrobials 2019 the ACSQHC Lunch Symposium will be held on Saturday 23 February 2019.
 
Australian Passive AMR Surveillance (APAS): learnings from long term trend analysis 2006-2017
APAS was established by the Commission in 2015 with the support of Queensland Health, which enabled access to the OrgTRx system as the information technology infrastructure. APAS collects, analyses and reports on de-identified patient level AMR data contributed by 10 public and private pathology services across Australia. These laboratories detect AMR in isolates referred from public and private hospitals, aged care homes and community settings. APAS includes data captured from January 2015 from all contributing laboratories; and historical data from four of those laboratories; there are currently over 50 million AMR records from 2006 to 2018.
 
The symposium will provide an overview of long term trends for some significant resistances in Australia, including methicillin resistance in Staphylococcus aureus, fluoroquinolone non-susceptibility in Escherichia coli, and vancomycin non-susceptibility in Enterococcus faecium. The implications for antimicrobial stewardship, infection prevention and control, and Australia’s response to AMR will be examined via a facilitated audience discussion.
 
Speakers:
Professor John Turnidge AO, Senior Clinical Advisor, AURA Surveillance System, Australian Commission on Safety and Quality in Health Care
Dr Kathryn Daveson, Clinical Advisor,  AURA Surveillance System, Australian Commission on Safety and Quality in Health Care
Ms Jan Bell, Scientific Advisor, AURA Surveillance System, Australian Commission on Safety and Quality in Health Care
 
Important Antimicrobials 2019 Dates
Early Bird Registration Deadline: Friday 4 January 2019
Accommodation Booking Deadline: 11 January 2019

 
Antimicrobials 2019 Registration: www.antimicrobials2019.com
14 Dec 2018
Antimicrobials 2019 Update: BD Breakfast Symposium
Antimicrobials 2019
21 - 23 February 2019
Sheraton Grand Sydney Hyde Park, Sydney

www.antimicrobials2019.com
 
BD Breakfast Symposium
 
During Antimicrobials 2019 the BD Breakfast Symposium will be held on Friday 0700 - 0845 22 February 2019.
 
"From the basement to the corner office- increasing the influence of the microbiology laboratory in antimicrobial stewardship.”
 
Speakers:
 
Dr. Michael Addidle, MBChB, MRCP, FRCPath & DTM&H : “The influence of diagnostic stewardship on antimicrobial stewardship
Dr Michael Addidle is a UK trained Clinical Microbiologist who holds consultant posts in both diagnostic and public health laboratories in New Zealand. Michael has a keen interest in the emerging field of diagnostic stewardship, and the development of strong relationships between the microbiology laboratory staff and ward clinicians. Michael  currently works at Pathlab Tauranga, New Zealand.
 
Dr Patrick Murray, PhD  :  “ The role of the laboratory in accelerating patient outcomes”
Dr. Patrick R. Murray received his Ph.D. degree in Microbiology at UCLA, postgraduate training in Clinical Microbiology at the Mayo Clinic in Rochester MN, and was director of the Clinical Microbiology Laboratories at Barnes Hospital and Professor of Medicine and Pathology at Washington University from 1976-1999. In 1999 he joined the faculty of the University of Maryland School of Medicine and in 2001 he accepted the position of Senior Scientist and Chief of Microbiology at the National Institutes of Health. In July 2011 he retired from the NIH and accepted his current position at BD Diagnostics as Vice President, Worldwide Scientific Affairs. He has authored more than 275 research articles and 20 books and has been the recipient of numerous awards and recognitions globally.
 
Caitlin Asjes : “ Money talks – making the economic case for antimicrobial stewardship”
Caitlin Asjes is BD’s Public Policy Director for Greater Asia. In this role, Caitlin supports key initiatives where BD’s business goals are aligned to government priorities to increase patient access and address unmet health needs.  With a background in health economics, Caitlin has worked across government, business, and civil society to support public health programs.
 
All registered Antimicrobials 2019 delegates are invited to the breakfast. Registration details will be available closer to the meeting
 
Important Antimicrobials 2019 Dates
Early Bird Registration Deadline: Friday 4 January 2019
Accommodation Booking Deadline: 11 January 2019

 
Antimicrobials 2019 Registration
www.antimicrobials2019.com
4 Dec 2018
Antimicrobials 2019 Update: Abstract submissions close this Friday
Antimicrobials 2019
21 - 23 February 2019
Sheraton Grand Sydney Hyde Park, Sydney

www.antimicrobials2019.com

Abstract Submission Deadline: Friday 7 December 2018
 
During Antimicrobials 2019 four oral proffered paper sessions have been scheduled. The poster sessions will be held on Thursday and Friday during the afternoon tea break
 
The ASA Travel Award
ASA has made funds available for travel awards to assist Members wanting to attend the Society's annual scientific meeting. Awards are made to ASA financial members presenting a proffered paper (oral or poster) at the meeting.  Applicants must have current ASA membership and must have been ASA members for at least the last 12 months. The awards consists of a return economy airfare, accommodation and conference registration up to the value of AUD2,500. 
 
ASA members who wish to apply for this award are invited to submit their application to the ASA Secretary Denise Daley at info@asainc.net.au by Friday 7 December 2018.  The application should include a copy of the abstract and for abstracts with more than one author, a letter stating the relative contribution of the applicant towards the research
 
The ASA Poster Travel Award
This is awarded to an individual on the basis of a poster presented during the ASA's Annual Scientific Meeting. The awards consists of a return economy airfare, accommodation and conference registration up to the value of AUD2,500 for the recipient to attend Antimicrobials 2020. 
 
The bioMerieux ASA Identifying Resistance Travel Award
This is awarded to an individual on the basis of a proffered paper (oral or poster) presented during the ASA's Annual Scientific Meeting dealing with the identification of antimicrobial resistance in a routine clinical setting. The award consists of AU$1000 cash prize, a commemorative plaque, and the provisions of flights, accommodation and registration for the recipient to attend Antimicrobials 2020. 
 
Important Dates
Abstract Submission Deadline: Friday 7 December 2018
Abstract Notification: Friday 14 December 2018
Early Bird Registration Deadline: Friday 4 January 2019
Accommodation Booking Deadline: 11 January 2019
29 Nov 2018
Antimicrobials 2019: Outpatient Parenteral Antibiotic Therapy (OPAT)/ Hospital in The Home (HITH)
The University of Queensland’s Centre for Research Excellence in Redefining Antibiotic Use to Reduce Resistance (CRE REDUCE) will be hosting an Outpatient Parenteral Antibiotic Therapy (OPAT)/ Hospital in The Home (HITH) Seminar in February next year. The Seminar will take place at St Vincent’s hospital in Sydney immediately prior to the Australian Society for Antimicrobials Annual Scientific meeting.
 
OPAT/ HITH is increasing in popularity and usage globally. This practical seminar will aim to provide guidance on all aspects relevant to delivering an optimal OPAT/ HITH service. We are honoured to be hosting Dr Mark Gilchrist from Imperial College London as well as an exciting Australian faculty.
 
Date: Wednesday 20 February, 2018
Venue: Victor Change Cardiac Institute, St Vincent’s Hospital, Darlinghurst, Sydney
 
Learning Objectives:
  • Understand the role of antimicrobial stewardship for provision of an OPAT service
  • Understand new international recommendations around drug solution-stability characteristics suitable for OPAT
  • Understand how to establish a new or optimise an existing OPAT service
  • Understand the role of dose optimisation within OPAT
  • Understand strengths and weaknesses of different infusor consumables
 
For more information and to register please visit the CRE REDUCE website.
29 Nov 2018
Antimicrobials 2019 Update: Abbott Breakfast Symposium
Antimicrobials 2019
21 - 23 February 2019
Sheraton Grand Sydney Hyde Park, Sydney
 
Abbott Breakfast Symposium
 
During Antimicrobials 2019 the Abbott Breakfast Symposium will be held on Saturday 0700 - 0845 23rd February 2019
 
From the lab to the patient: Navigating local and international testing pathways for C. difficile infection.
 
Clostridium difficile has recently come to the forefront again with the release of new European and US guidelines which emphasize the importance of the multi-step algorithm approach to prevent over-diagnosis.  The symposium will outline the changing epidemiology of C. difficile disease and developing antimicrobial resistance. We will compare international guidelines with current Australian testing practices and provide an overview of a decentralized testing approach by a large pathology network.  With Professor Tom Riley, Professor Tony Korman and Dr. Jacqueline Harper as speakers, the morning is set to be entertaining and informative.
 
About the speakers
 
Professor Thomas V Riley
BAppSc (Curtin), MAppEpid (ANU), PhD (UWA), FASM, FRCPath, FAAM, FFSc (RCPA)
Tom Riley is currently a Professorial Research Fellow at Edith Cowan University and Professor of Public Health at Murdoch University, both in Perth. He maintains his appointment with PathWest Laboratory Medicine. Tom is a Fellow of the Royal College of Pathologists, the Australian Society for Microbiology, the American Academy of Microbiology and the Faculty of Science of the Royal College of Pathologists of Australasia and has published nearly 400 book chapters and refereed journal articles. He has had a longstanding interest in healthcare related infections, particularly the diagnosis, pathogenesis and epidemiology of Clostridium difficile infection (CDI), and started working on CDI in animals over 20 years ago.  The main focus of his research currently is CDI and One Health.
 
Associate Professor Tony Korman
MBBS (Hons) (Monash), FRACP, FRCPA, MASM
Tony Korman is the Director of Infectious Diseases and Director of Microbiology at Monash Health, Victoria's largest health service, and Infection theme leader, Centre for Inflammatory Diseases, and Associate Professor, Department of Medicine, School of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University.
 
Dr. Jacqueline Harper
BSC (Hons), PhD, FASM, DipBus (AIM)
Jacqueline Harper has a PhD in Medical Microbiology from University of Queensland and is a Fellow of the Australian Society for Microbiology. She is Principal Chief Scientist in Microbiology for Pathology Queensland which is a network of 35 laboratories providing diagnostic services for all public hospitals throughout the state. She manages the Microbiology Laboratory at the Central Laboratory in Brisbane and oversees Microbiology operations in all Pathology Queensland laboratories.
 
All registered Antimicrobials 2019 delegates are invited to the breakfast.  Registration details will be available closer to the meeting 
 
Important Antimicrobials 2019 Dates
Abstract Submission Deadline: Friday 7 December 2018
Abstract Notification: Friday 14 December 2018
Early Bird Registration Deadline: Friday 4 January 2019
Accommodation Booking Deadline: 11 January 2019
 
Antimicrobials 2019 Registration and Abstract Submission
1 Nov 2018
Antimicrobials 2019 Update: EUCAST Workshop
Antimicrobials 2019
21 - 23 February 2019
Sheraton on the Park, Sydney
 
 
Prior to Antimicrobials 2019 ASA will be holding a EUCAST Workshop

Open to all registered Antimicrobials 2019 delegates (register via the Antimicrobials 2019 registration portal - www.antimicrobials2019.com), this Workshop is designed as an interactive forum for EUCAST users and non-users alike to hear the latest on EUCAST activities, discuss some of the more challenging areas of testing, and discuss any and all implementation issues.

Time: 14:00 pm - 17:30 pm
Date: Wednesday 20 February 2019
Venue: Pullman Hyde Park


Program
1. Update on EUCAST activities John Turnidge
2. The New Susceptible - Increased exposure (Intermediate) John Turnidge
3.  Troublesome antimicrobials (esp. colistin and fosfomycin) Lou Cooley
4. Haemophilus influenzae testing issues Shelanah Fernando
5.  What are ECOFFs and why do they matter? John Turnidge
6. Selective / cascade reporting Maryza Graham
7.  CPE detection (and how effective is it?) Tom Gottlieb
8.  EUCAST antifungal testing  Sharon Chen
9. Non-tuberculous Mycobacteria and Nocardia Jenny Robson
10.  VetCAST/VAST (What's going on with them) John Turnidge
11.  Tips and tricks in susceptibility testing John Turnidge
 
Important Antimicrobials 2019  Dates
 
Abstract Submission Deadline: Friday, 7th December 2018
Abstract Notification: Friday, 14th December 2018
Early Bird Registration Deadline: Friday, 4th January 2019
Accommodation Booking Deadline: Friday, 11 January 2019
12 Oct 2018
Antimicrobials 2019 Update: Howard Florey Oration
Antimicrobials 2019
21 - 23 February 2019
Sheraton on the Park
 
The Howard Florey Oration is delivered each year during the Society's annual scientific meeting and is presented by a scientist who has made a significant contribution to a greater understanding of antimicrobials and their appropriate use. 
 
The Antimicrobials 2019 Howard Florey Oration will be delivered by Professor Monica Slavin, Head, Infectious Diseases and Infection Control at the Peter MacCallum Cancer Centre. 
 
Professor Slavin is a Professor in the Department of Medicine at The University of Melbourne and a Research Associate at the Macfarlane Burnet Centre for Medical Research and Public Health. She received her medical degree from The University of Melbourne and trained in Infectious Diseases in Melbourne and Seattle, USA. Her major research interest is in infections in the immunocompromised, especially patients with cancer and those undergoing transplantation. Her current research focus is prevention and early treatment of invasive fungal infections in haematology patients. She has served on national steering committees for the development of antifungal and fever and neutropenia treatment guidelines and for the conduct of Australia-wide studies of epidemiology of fungal infection.
 
Professor Slavin's oration, "Fungus Fights Back" will be discussing the emergence of antifungal resistance and changes in fungal epidemiology.    
 
 
Important Dates
 
Abstract Submission Deadline: Friday, 7th December 2018
Abstract Notification: Friday, 14th December 2018
Early Bird Registration Deadline: Friday, 4th January 2019
Accommodation Booking Deadline: Friday, 11 January 2019
 
Abstract submission and meeting registrations: www.antimicrobials2019.com
21 Aug 2018
Antimicrobials 2019: Program Update
Antimicrobials 2019
21 - 23 February 2019
Sheraton on the Park, Sydney
 
The Australian Society for Antimicrobials is pleased to announce Professor Jan Kluytmans will be presenting the keynote lecture "Controlling Antimicrobial Resistance by Visualising the Invisible".
 
Professor Kluytmans, Consultant Microbiologist and Professor of Epidemiology of Healthcare-related Infections in the Netherlands has developed a bundle of scores to determine if a healthcare institute (hospital, nursing home, rehab institute etc.) has an adequate infection control and antimicrobial use. The system has being implemented in a European cross border project using innovative technology to perform the measurements and provide feedback.
 
Antimicrobials 2019 Important Dates
Abstract Submission Deadline: Friday 7th December 2018
Early Bird Registration Deadline: Friday 4th January 2019
Abstract Notification Deadline: Friday 14th December 2018
 
For further information on the meeting: www.antimicrobials2019.com
 
For meeting program click here.
3 Jul 2018
Antimicrobials 2019 Website Now Available
Antimicrobials 2019
21 - 23 February 2019
Sheraton on the Park, Sydney
 
Meeting Website for registration and abstract submission now available: www.antimicrobials2019.com
 
On behalf of the Australian Society for Antimicrobials, I would like to invite you to the Society's 20th Annual Scientific Meeting, "Antimicrobials 2019", to be held at the Sheraton on the Park, Sydney Thursday 21st - Saturday 23rd February 2019.

I am pleased to announce Romney Humphries, Accelerate Diagnostics and the American Society for Microbiology, USA; Jesús Rodriguez-Baño, Saville University and President of the European Society for Microbiology and Infectious Diseases, Spain; and Karin Thursky, The University of Melbourne, Australia will be participating at the meeting. Romney will be presenting the plenary "Antimicrobial susceptibility testing: Old technologies for new drugs and new technologies for old drugs", Jesús will be presenting "New antimicrobials: Can we avoid our past mistakes?" and Karin will be presenting the plenary "Antimicrobial stewardship in Australia: Leaders or laggards?". 

The 2019 Howard Florey Oration will be delivered by Monica Slavin from The University Of Melbourne, Australia. 

The programme's symposia cover many different aspects of antimicrobials and sessions include "Difficult to treat populations (Science and immunology)", "Difficult to treat/ID organisms (Laboratory and technical aspects)", "Technology and antimicrobial resistance", "Where humans and animals collide", and "AMR testing update". In addition, we will have an AMR update summit panel discussion and two pharmacy symposia titled "The drugs" and "Drugs and bugs". Two literature review sessions will also be presented, including "The year in clinical microbiology" (Tony Korman, Victoria) and "The year in AMR" (Elaine Cheong, New South Wales). Four proffered papers and two poster sessions are also planned for the meeting. 

To promote discussion and interaction between delegates and the invited speakers, the meeting's registration includes lunches, morning and afternoon teas and admission to the Howard Florey Dinner. 

I am confident that you will find the meeting's programme both scientifically stimulating and informative and we look forward to meeting you in Sydney.

Ben Howden
President ASA


Important Dates

Abstract Submission Deadline: Friday, 7th December 2018
Abstract Notification: Friday, 14th December 2018
Early Bird Registration Deadline: Friday, 4th January 2019
Accommodation Booking Deadline: Friday, 11 January 2019
2 Jul 2018
ISSSI 2018 Travel Scholarship Recipient
ISSSI 2018 Travel Scholarship Recipient
Copenhagen, Denmark
23 - 26 August 2018
 
The Australian Society for Antimicrobials congratulates the following ASA members on being awarded an ASA ISSSI Travel Scholarship to attend the 2018 International Symposium on Staphylococci and Staphylococcal Infections in Denmark.
 
Sarah Baines. The University of Melbourne. Australia. Comprehensive Genomic Investigation of Staphylococcus aureus Bacteraemia in Australia
 
Stanley Pang. Murdoch University, Australia. Genetic Diversity and Geographical Distribution of Bactereamic Methicillin-resistant Staphylocococcus aureus in Australia
 
The scholarship consists of $3,000 each to assist in the return economy airfare, accommodation and conference registration.  As part of the scholarship the recipients will  provide a report on the meeting for the ASA Newsletter.
1 Jul 2018
Antimicrobials 2019: Programme OUT NOW!
On behalf of the Australian Society for Antimicrobials, I would like to invite you to the Society's 20th Annual Scientific Meeting "Antimicrobials 2019" to be held at the Sheraton on the Park, Sydney, on Thursday 21st - Saturday 23rd February 2019. 
 
In our nineteen previous ASA meetings we have had up to 400 registrants per meeting, and we hope to improve on that in 2019 as word continues to spread about the quality of our meeting.
 
I am pleased to announce Romney Humphries, Accelerate Diagnostics and the American Society for Microbiology, USA; Jesús Rodriguez Baño, Saville University and President of the European Society for Microbiology and Infectious Diseases, Spain; and Karin Thursky, The University of Melbourne, Australia will be participating at the meeting.  Romney will be presenting the plenary “Antimicrobial susceptibility testing: Old technologies for new drugs and new technologies for old drugs”, Jesús will be presenting “New antimicrobials: Can we avoid our past mistakes? and Karin will be presenting the plenary ‘Antimicrobial stewardship in Australia: Leaders or laggards?”.
 
The 2019 Howard Florey Oration will be delivered by Monica Slavin from the University of Melbourne, Victoria.  
 
The programme’s symposia cover many different aspects on antimicrobials and sessions include “Difficult to Treat Populations (Science and Immunology)”, “Difficult to Treat/ID Organisms (Laboratory and Technical Aspects)”, “Technology and Antimicrobial Resistance”, “Where Humans and Animals Collide", and “AMR Testing Update”.  In addition, we will have an AMR Update Summit Panel Discussion and two pharmacy symposia titled “The Drugs” and “Drugs and Bugs”.  Two literature review sessions will also be presented including “The Year in Clinical Microbiology” (Tony Korman, Victoria), and “The Year in AMR and AMS” (Elaine Cheong, New South Wales). Four proffered papers and two poster sessions are also planned for the meeting.
 
As occurred during Antimicrobials 2018, the “Antimicrobials 2019” registration will include a formal dinner for the Howard Florey Dinner which will be held at the Sheraton on the Park.
 
To promote discussion and interaction between delegates and the invited speakers the meeting’s registration will include lunches, morning and afternoon teas.
 
I am confident that you will find the meeting's program both scientifically stimulating and informative, and we look forward to meeting you in Sydney.
 
Ben Howden
ASA President
 
Please click here for the Programme
 
For more information, please visit www.antimicrobials2019.com
 
Please note that programs are subject to change. We recommend that you check back in the days preceding the Meeting for the most up to date program.
6 Jun 2018
PK PD Workshop and Drug Dosing Symposium
Advanced Pharmacokinetic/ Pharmacodynamic Modelling Workshop
Date: 13- 15 September 2018
Venue: Union College, University of Queensland, St Lucia Campus, Brisbane
Cost: $660pp
 
This workshop aims to build capacity in pharmacokinetic modelling and dose optimisation of antimicrobials so that attendees will be able to design and analyse clinical, in vitro or animal studies with the aim of informing robust dosing regimen selection.
 
The objectives of this workshop will be to:
-              Create PK and PK/PD datasets appropriate for population analysis
-              Fit models to data to estimate population and individual distribution of parameter values
-              Make and customize pharmacometric plots
-              Perform basic and Monte Carlo simulations for PK-PD analysis of antimicrobials
 
This 2.5-day workshop will host an International Faculty as well as delegates from a variety of backgrounds including pharmacy, infectious diseases, critical care and nephrology. Faculty includes A/ Prof Michael Neely, Dr Catherine Byrne, Dr Christina Koenig and Prof Jason Roberts.
 
To register and for more information click here.
 
Symposium on Drug Dosing Studies
Date: 20 September 2018
Venue: UQCCR, University of Queensland, Royal Brisbane and Women’s Hospital Campus, Brisbane
Cost: $77pp
 
The Symposium will cover a range of topics, focusing on: innovation in patient-centric sampling, applications of microsampling for drug dosing (both in the clinical and research environment), and novel bioanalytical methods. The Symposium will explore the application of these alternative sampling strategies as applied to the hospital, outpatient and community environments.
For more information click here.
7 May 2018
Antimicrobials 2019
Antimicrobials 2019
21st - 23rd February 2019
 
The venue for Antmicrobials 2019 has now been confirmed and will held at the Sheraton on the Park, Sydney. The meeting website www.antimicrobials2019.com will be available in July 2018.
Please do not hesitate to contact ASA if you have any queries regarding sponsorship, meeting registration and abstract submission. 
19 Feb 2018
Antimicrobials 2018: MSD Industry Sessions Update
Antimicrobials 2018
22 - 24 February 2018
Brisbane Exhibition and Convention Centre, Brisbane
 
MSD Industry Symposia Update
 
Thursday 22nd February 2018 CDI Lunch Time Symposium
A/Prof  Natalie Schellack  (Chair) 
Prof Mark Wilcox – Antitoxin for the Prevention of Recurrent CDI
A/Prof Tony Korman – Management of Recurrent CDI
Prof Yehuda Carmeli – Clinical and Economic Consequences of Recurrent CDI
 
Friday 23rd February 2018 Gram-negative Infection Lunch Time Symposium: Pseudomonas - From bench to bedside
Prof David Paterson (Chair)
Prof Iain Lamont – ‘Superbug Pseudomonas’
Prof Yehuda Carmeli - Challenges to Adequate Therapy for Pseudomonas aeruginosa – Why, When and Who to Treat
Dr Petrick Periyasamy - Practical Application of Risk Factors in Complex Patients in Malaysia
 
Saturday 24th February 2018 AMS Breakfast Time Symposium
Title: AMS Breakfast Discussion: Natalie Schellack
Time: 0700 - 0845
Venue: Room B3 Boulevard Level
Dr Ankur Gupta – (Chair)
Prof Natalie Schellack - Optimising Technology in AMS
Panel Discussion:
Panellists – A/Prof Natalie Schellack, Prof Mark Wilcox, Dr Petrick Periyasamy, Prof Yehuda Carmeli, Dr David Andresen, Dr Minyon Avent, Dr David Grolman
 
If you unable to attend the conference the MSD symposiums will be live streamed to registered health care professionals in Australia/ NZ on the day and accessible up to 24 hours after the events. Highlite the website links to register to access the live streams.
 
Although  ASA delegates are invited to attend all MSD sessions, delegates must pre register for the MSD AMS Breakfast Session.  Please note spaces are limited for the breakfast session.
 
Antimicrobials2018 Meeting Registration: www.antimicrobials2018.com
23 Jan 2018
Antimicrobials 2018: MSD Breakfast Symposium
Antimicrobials 2018
22 - 24 February 2018
Brisbane Convention and Exhibition Centre

www.antimicrobials2018.com
 
MSD Breakfast Symposium
 
During Antimicrobials 2018 MSD will be holding a breakfast symposium on Saturday 24th February (0700 - 0845)
 
Title: Antimicrobial Stewardship
 
Speaker: A/Prof Natalie Scellack, School of Pharmacy, Sefako Makgatho Health Sciences University, South Africa
 
Natalie Schellack is an Associate Professor and Acting Head of the Division for Clinical Pharmacy in the Department of Pharmacy, Sefako Makgatho Health Sciences University. She holds three degrees, two bachelor degrees (nursing and pharmacy) and a PhD in pharmacy. She is part of the editorial team of the Journal of Hospital Administration (Canadian Journal), serves on the Gauteng Provincial Pharmacy and Therapeutics Committee, and Sefako Makgatho Health Sciences Research and Ethics Committee. She is also the chairperson of the South African Society of Clinical Pharmacy.
 
She serves on the Gauteng Provincial Pharmacy and Therapeutics committee and nationally she serves as a member of the Paediatric Essential Medicine List, she is a cofounder and currently the chairperson of the South African Society of Clinical Pharmacy (SASOCP), she is a member of the South African Global Antimicrobial Resistance Partnership (GARP) and the  Federation of Infectious Diseases Societies of Southern Africa (FIDSSA).
 
in 2018 she has been nominated as the woman of the year – health care category for “woman of stature” in South Africa.  
 
The MSD breakfast session is available to all registered Antimicrobials 2018 delegates. An email inviting delegates to attend the breakfast will be circulated closer to the meeting.
18 Jan 2018
Antimicrobials 2018: Cepheid Breakfast Symposium
Antimicrobials 2018
22 - 24 February 2018
Brisbane Convention and Exhibition Centre

www.antimicrobials2018.com
 
Cepheid Breakfast Symposium
 
During Antimicrobials 2018 Cepheid will be holding a breakfast symposium on Saturday 24th February (0700 - 0845)
 
Title: Next Generation Xpert MTB/RIF Ultra: Early Experince in a Low Burden Setting
 
Speaker: Dr Sushil Pandey, Queensland Mycobacterium Reference Laboratory, Pathology Queensland
 
The Cepheid breakfast session is available to all registered Antimicrobials 2018 delegates. An email inviting delegates to attend the breakfast will be circulated closer to the meeting

Antimicrobials 2018 Important Dates:
Accommodation Booking Deadline: Friday, 19 January 2018
11 Jan 2018
Antimicrobials 2018: bioMerieux Breakfast Symposium
Antimicrobials 2018 
22 - 24 February 2018
Brisbane Convention and Exhibition Centre
 
bioMerieux Breakfast Symposium
During Antimicrobials 2018 bioMerieux will be holding a breakfast symposium on Thursday 22nd February (0700 - 0845)
 
Title: How can the MIC guide antibiotic choices and doses in sepsis? 
Speaker: Professor Jason Roberts
 
The talk will cover both theory and clinical cases on following issues:
·         Data on the timeliness of effective antibiotic therapy in critically ill/septic patients
·         What is an MIC and what are the various forms?
·         What data exists relating different MICs to changes in patient outcomes?
·         How to include both considerations of pharmacokinetics and MIC in decisions to ensure better dosing for patients?
 
Professor Jason Roberts is a National Health and Medical Research Council Practitioner Fellow at The University of Queensland and Consultant Clinical Pharmacist at the Royal Brisbane and Women’s Hospital. He is Director of Centre of Research Excellent REDUCE within the University of Queensland Centre for Clinical Research and is Director of the Centre for Translational Anti-infective Pharmacodynamics in the School of Pharmacy where he is also Chair of the Research Strategies Committee. 
 
Professor Roberts has a strong interest in research and his principal research theme is optimization of antibiotic dosing in the critically ill. He has been invited to present his results at major international conferences in critical care, infectious diseases, pharmacy, nephrology, transplantation and safety. He has published over 300 papers and book chapters and has >$25 million in grant funding for his research topics.
 
The bioMerieux breakfast session is available to all registered Antimicrobials 2018 delegates.  An email inviting delegates to attend the breakfast will be circulated closer to the meeting
 
 
Antimicrobials 2018 Important Dates
Accommodation Booking Deadline: Friday, 19 January 2018
11 Jan 2018
Antimicrobials 2018: BD Breakfast Symposium
Antimicrobials 2018
22 - 24 February 2018
Brisbane Convention and Exhibition Centre
 
BD Breakfast Symposium
 
During Antimicrobials 2018 BD will be holding a breakfast symposium on Friday 23rd February (0700 - 0845)
 
Title: The epidemiology of carbapenemase associated infections and the role of the laboratory in their detection
 
Speakers:
·       Dr. Tony Korman, Infectious Diseases Physician and Medical Microbiologist, Monash Medical Centre
 
·       Mr. Justin Ellem, Hospital Scientist, Westmead ICPMR
 
The BD breakfast session is available to all registered Antimicrobials 2018 delegates. An email inviting delegates to attend the breakfast will be circulated closer to the meeting
 
Antimicrobials 2018 Important Dates:
Accommodation Booking Deadline: Friday, 19 January 2018
29 Dec 2017
Antimicrobial 2018: Travel Awards
Antimicrobials 2018
Brisbane Exhibition and Convention Centre, Brisbane Queensland
22 - 24 February 2018
 
The ASA Committee congratulates the following ASA members  who have received an ASA Travel Award to attend Antimicrobials 2018:
  • Sam Abraham. Murdoch University, Western Australia. Australian Silver Gulls (Chroicocephalus novaehollandiae) are carriers of pathogenic, globally disseminated, pandemic and critically important antimicrobial resistant Escherichia coli
 
  • Daniel Knight. Murdoch University, Western Australia. Antimicrobial resistance in zoonotic lineages of Clostridium difficle  
 
  • Terence Lee. Murdoch University, Western Australia.Characterization of ST173 vanB E. faecium from the first VRE outbreak in Western Australia
 
Important Dates
Early Bird Registration Deadline: Friday 5 January 2018
29 Dec 2017
Antimicrobials 2018: MSD Industry Sessions
Antimicrobials 2018
22 - 24 February 2018
Brisbane Exhibition and Convention Centre
www.antimicrobials2018.com
 
 
MSD is pleased to invite you to their symposia on furthering understanding of contemporary infection and resistance issues at the 2018 ASA Annual Scientific Meeting at the Brisbane Convention and Exhibition Centre. Should you be unable to attend in person MSD will be broadcast live and available online for 24 hours.
 
Sessions:
  • C Difficile Infection Lunch Time Symposium: 22nd February 2018 Time: 1-2:30pm
  • Gram-negative Infection Lunch Time Symposium: 23rd February 2018 Time: 1-2:30pm
  • Antimicrobial Stewardship Breakfast Symposium: 24th February 2018 Time: 7-9am 
 
MSD speakers will be confirmed in the new year
 
Important Dates:
 
Early Bird Registration Deadline: Friday, 5 January 2018
Accommodation Booking Deadline: Friday, 19 January 2018
16 Nov 2017
One Health AMR Website
The Office of Health Protection  are pleased to announce that the Minister for Health and Minister for Agriculture and Water Resources have released the new One Health AMR website: https://www.amr.gov.au
 
The website includes a research and activity directory which aims to collect and share information about AMR-related initiatives that are being undertaken across Australia. The Office of Health Protection encourages submission of any AMR-related research and activities you are undertaking in the Directory.
16 Nov 2017
Call for expressions of interest: Australian EUCAST National AST Committee
CALL FOR EXPRESSIONS OF INTEREST
 
ASA EUCAST National AST Committee (AusNAC)
 
Background
The Australian EUCAST National AST Committee (AusNAC) was established in 2011 to provide expert advice and further the cause of skill development in the area of antimicrobial susceptibility testing. It is the affiliated national committee within the European Committee on Antimicrobial Susceptibility Testing (EUCAST) network (http://www.eucast.org/organization/nac/). EUCAST now has national advisory committees (NACs) in 37countries, including 9 outside Europe, and continues to expand its membership. Its Terms of Reference are listed below.
 
Expression of interest
The Australian Society for Antimicrobials is calling for expressions of interest to joint AusNAC from those with a strong interest in the laboratory and clinical aspects of phenotypic antimicrobial susceptibility testing, and willing to make an active contribution to its activities.
 
AusNAC is keen to update and expand its areas of activity and expertise in the area of phenotypic antimicrobial susceptibility testing, and focus on the promotion of the EUCAST AST system across Australia. EUCAST currently addresses all aspects on phenotypic AST of antibacterial and antifungal agents in human medicine. It is currently working to develop methods and breakpoints for veterinary agents (VetCAST - http://www.eucast.org/ast_of_veterinary_pathogens/), and antimycobacterial agents (AMST - http://www.eucast.org/mycobacteria/), both of which now have working subcommittees.
 
Terms of reference
  • Promote EUCAST as the preferred system for phenotypic antimicrobial susceptibility testing
  • Provide advice to EUCAST Steering Committee on items for General Consultation (http://www.eucast.org/documents/consultations/)
  • Assist laboratories in transitioning from CLSI or CDS to EUCAST methods and breakpoints (where available)
  • Provide a representative to the General Committee of EUCAST
  • Provide laboratory support to EUCAST development activities when requested, within existing resources
  • Provide expert advice to laboratories and other stakeholders Australia-wide on all aspects of phenotypic susceptibility testing
  • Provide advice to device manufacturers on preferred testing ranges and other aspects of devices and supplies as requested or required for the Australian environment
  • Provide advice to resistance surveillance groups on laboratory methods, testing concentrations, and interpretation of data relevant to the type of resistance surveillance being undertaken
  • Run educational workshops on basic and advanced aspects of susceptibility testing
  • Liaise with other international standards setting bodies such CLSI and ISO.
Expressions of interest should be forwarded to John Turnidge (jturnidge@gmail.com) by November 30, 2017. Include in your email a brief statement of your area of expertise and the contribution that you can make.
2 Jul 2017
Antimicrobials 2018: ASA Poster Travel Award
The ASA Poster Travel Award
 
This is awarded to an individual on the basis of a poster presented during the ASA's Annual Scientific Meeting. 
 
The applicant must be a financial member of the ASA. The Award is restricted to ASA members residing in Australia or New Zealand.  The award committee will take into account the quality and originality of the poster.
 
The awards consists of a return economy airfare, accommodation and conference registration up to the value of AUD2,500 for the recipients to attend Antimicrobials 2019. The award committee will consist of three ASA committee members.
2 Jul 2017
Antimicrobials 2018: Travel Award
The ASA Travel Award
 
ASA has made funds available for travel awards to assist Members wanting to attend the Society's annual scientific meeting. Awards are made to ASA financial members presenting a proffered paper (oral or poster) at the meeting.  Applicants must have current ASA membership and must have been ASA members for at least the last 12 months. Recipients of  an Award are required to write a report on the meeting for the ASA Newsletter.  
 
The awards consists of a return economy airfare, accommodation and conference registration up to the value of AUD2,500. 
 
ASA members who wish to apply for this award are invited to submit their application to the ASA Secretary Denise Daley at info@asainc.net.au.  The application should include a copy of the abstract and for abstracts with more than one author, a letter stating the relative contribution of the applicant towards the research.
2 Jul 2017
Antimicrobials 2018: Program
On behalf of the Australian Society for Antimicrobials, I would like to invite you to the Society's 19th Annual Scientific Meeting "Antimicrobials 2018" to be held at the Brisbane Convention and Exhibition Centre, Brisbane, on Thursday 22nd - Saturday 24th February 2018. 
 
I am pleased to announce Lance Price, George Washington University, USA; Matthew Holden, University of St Andrews, UK; and Greg Cook, University of Otago, New Zealand will be participating at the meeting. Lance will be presenting the plenary "Food Producing Animals as a Source of Antimicrobial Resistance (AMR)", Matthew will be presenting "Using Genomics to AMR in Hospitals", and Greg will be presenting the plenary "Targeting mycobacterial energetics to fight drug-resistant tuberculosis".
 
The 2018 Howard Florey Oration will be delivered by John Turnidge, University of Adelaide, South Australia.
 
The programme's symposia cover many different aspects on antimicrobials and sessions include "Drug Discovery and Therapeutic Options", "The Environment as a Source of AMR", "Rise of the Superbugs", "The Immunocompromised Host", "Linking Antimicrobial Stewardship (AMS) and Laboratory Diagnostics: The Role of the Laboratory in AMS", and "The Future of the Diagnostic Microbiology Laboratory". In addition, we have two pharmacy symposia on Saturday afternoon titled "AMS" and "Drugs and Bugs". Three literature review sessions will also be presented, including "The Year in Clinical Microbiology" (Sally Roberts, New Zealand), "The Year in AMS" (Kirsty Buising, Victoria), and "The Year in AMR and Therapy" (Trent Yarwood, Queensland). Six proffered papers and two poster sessions are also planned for the meeting.
 
To promote discussion and interaction between delegates and the invited speakers, the meeting's registration includes lunches, morning and afternoon teas and admission to the Howard Florey Dinner.
 
I am confident that you will find the meeting's program both scientifically stimulating and informative, and we look forward to meeting you in Brisbane.
 
Ben Howden
ASA President
 
Antimicrobials 2018 Scientific ProgramClick Here

Please note that programs are subject to change. We recommend that you check back in the days preceding the Meeting for the most up to date program.
9 Feb 2017
ISC Travel Grants
ISC Grant Applications Now Invited
 
Fully Funded Travel Grants Available
 
In conjunction with abstract submission, the ISC is currently accepting applications for its grants to attend the International Congress of Chemotherapy and Infection 2017 (ICC 2017) which will take place 24-27 November in Taipei, Taiwan.   Application criteria for each grant can be found in the links below and applications are welcomed from members of ISC Member Societies.
 
ISC Young Investigator Travel Award
 
A number of ISC Young Investigator Travel Awards (YITA) will be given to applicants under the age of 35 attending the 30th ICC. The award will cover the airfare to the ICC and hotel accommodation as well as free registration.  Priority will be given to applicants from low resource countries.  All eligible young investigators who are submitting abstracts are encouraged to apply.  Click here for more information.
 
Tom Bergan Memorial Grant
 
This ISC grant has been established in memory of Tom Bergan, Past President of the ISC. The grant will cover the airfare to the ICC and hotel accommodation as well as free registration.  Priority will be given to applicants from low resource countries.  All eligible young investigators who are submitting abstracts are encouraged to apply.  Click here for more information.
 
John David Williams Memorial Grant
 
The JD Williams Memorial grant is established in memory of John David Williams, Past President of the ISC.  The grant will cover the airfare to the ICC and hotel accommodation as well as free registration.  Priority will be given to applicants from low resource countries.  All eligible young investigators who are submitting abstracts are encouraged to apply.  Click here for more information.
ISC Member Societies can advertise meetings on the ISC’s website by contacting secretariat@ischemo.org or by submitting details via the Contact page of the website.
30 Dec 2016
Antimicrobials 2017 and StaphPath 2017
Antimicrobials 2017 
Adelaide Convention Centre, Adelaide, South Australia 
23 - 25 February 2017
 
The Australian Society for Antimicrobials (ASA) congratulate the following ASA members on receiving an ASA Travel Award to attend Antimicrobials 2017: 
 
 
Sarah Baines. The University of Melbourne, Victoria, Australia. Evolving chlorhexidine tolerance with a prevalent hospital lineage of methicillin-resistant Staphylococcus aureus
 
Kate Worthing.  University of Sydney, New South Wales, Australia. Characterisation of novel SCCmec elements from methicillin-resistant Staphylococcus pseudintermedius from Australian animals
 
Indy Sandaradura. Westmead Hospital, New South Wales, Australia. Computerised fluconazole dose selection in critical illness
 
During ASA 2017 36 proferred papers and 48 posters will be presented
 
Early bird registrations for Antimicrobials 2017 and StaphPath 2017 close on Friday, 6 January 2017.  We recommend that you register now to secure your discounted registration fee. Please ensure that your registration is finalised prior to Friday, 6 January 2017 to receive the early bird rate.
 
To register for Antimicrobials 2017 and/or StaphPath 2017, please click here!
24 Oct 2016
Antibiotic Awareness Week 14 -20 November 2016
The Australian Commission of Safety and Quality in Health Care's  resources for Antibiotic Awareness Week (AAW) 2016 are now available to download from the Commission's website.
 
The following resources have been developed to assist hospitals and health service organisations in planning activities for the week. Additional resources for 2016 will be made available prior to the event.
 
·         Ideas for activities
·         Guide for planning activities and events
·         Antibiotic Awareness Week logo
·         Email signature block
·         CEO message template – for organisation-wide communication from your CEO
·         E-banner for your website
·         Antibiotic Awareness Week 2016 poster
·         Antibiotic Awareness Week 2016 MIND ME pocket card
·         Antibiotic Awareness Week pull-up banner for use at forums, seminars, presentations, or as part of AAW displays
·         Screensaver: Antibiotic Awareness Week – AMS Clinical Care Standard
 
Access these resources at www.safetyandquality.gov.au/aaw
 
In addition, the Commission has a limited number of Antibiotic Awareness Week t-shirt packs available. Each pack includes three t-shirts (sizes M, L and XL). If you would like to request a t-shirt pack, please email us at AAW@safetyandquality.gov.au
 
 
More information:
Enquiries about Antibiotic Awareness Week should be directed to AAW@safetyandquality.gov.au
 
 
1 Oct 2016
20th Lancefield International Symposium on Streptococci and Streptococcal Diseases
The Lancefield International Symposium on Streptococci and Streptococcal Diseases is a 3-yearly meeting that is the world’s premier meeting on streptococci and streptococcal diseases, especially Streptococcus pyogenes.
 
The 20th LISSSD will continue the tradition of linking laboratory excellence with high quality clinical and epidemiologic studies of streptococcal infections, but will bring a fresh and forward-looking approach with a focus on cutting-edge science, and on streptococcal disease in endemic regions. The meeting will especially encourage up-and-coming researchers by providing special opportunities for these researchers to attend at a lower cost as well as presenting in a dedicated session.
 
 
29 Sep 2016
Landmark declaration agreeing to combat antimicrobial resistance signed by 193 countries at the Unit
The agreement follows a worldwide campaign led by the Chief Medical Officer Professor Dame Sally Davies and Health Secretary Jeremy Hunt to highlight the threat posed to modern medicine by antimicrobial resistance (AMR).
Every signatory has agreed that drug resistant infections must be tackled as a priority. The nations have committed to:
·         develop surveillance and regulatory systems on the use and sales of antimicrobial medicines for humans and animals
·         encourage innovative ways to develop new antibiotics, and improve rapid diagnostics
·         raise awareness among health professionals and the public on how to prevent drug resistant infections
 
For further information: 
 
27 Aug 2016
30th International Congress of Chemotherapy and Infection (ICC 2017)
Taipei, Taiwan 
24th to 27th November, 2017.
 
Important dates:
Abstract submission system opens – 30th November, 2016
Abstract submission deadline – 31st May, 2017
Early-bird registration deadline – 30th September, 2017
 
The ICC 2017 official website is now on line, and will be posting more information in the near future. Please visit http://icc2017.tw/index.html
 
 
27 Aug 2016
AGAR 2014 Surveillance Reports
The AGAR 2014 antimicrobial resistance surveillance reports are now available in the Communicable Diseases Intelligence Volume 40 Number 2 June 2016 issue
 
 
Australian Group on Antimicrobial Resistance Australian Enterobacteriaceae Sepsis Outcome Programme annual report, 2014
Jan M Bell, John D Turnidge, Geoffrey W Coombs, Denise A Daley, Thomas Gottlieb, Jenny Robson, Narelle George 
Full text [HTML] | Full text [PDF 430 KB]
 
Australian Group on Antimicrobial Resistance Australian Enterococcal Sepsis Outcome Programme annual report, 2014
Geoffrey W Coombs, Denise A Daley, Yung Thin Lee, Stanley Pang, Julie C Pearson, J Owen Robinson, Paul DR Johnson, Despina Kotsanas, Jan M Bell, John D Turnidge for the Australian Group on Antimicrobial Resistance
Full text [HTML] | Full text [PDF 430 KB]
 
Australian Group on Antimicrobial Resistance Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 20145
Geoffrey W Coombs, Denise A Daley, Yung Thin Lee, Julie C Pearson, J Owen Robinson, Graeme R Nimmo, Peter Collignon, Benjamin P Howden, Jan M Bell, John D Turnidge for the Australian Group on Antimicrobial Resistance
 
15 Aug 2016
ASA Annual Research Grant

An Annual grant of up to $25,000 to support original research ha been made available by the Australian Society of Antimicrobials (ASA). The following conditions apply:

 

  • Funding is limited to ASA financial members.
  • The Principal Investigator (PI) must have been an ASA member for at least twelve months
  • The successful applicant will present their work at an ASA annual scientific meeting
  • If applicable the PI will submit an article for the ASA newsletter and website
  • ASA will be acknowledged on all resulting publications and presentations
  • 12 and 24 month progress reports must be submitted to the ASA committee

 

The research funds are to be used for the project, as per the budget application only. ASA does not support an institution's  infrastructure or overhead costs.

 

The application must be performed on line via the ASA website Research Grant Application Form and must include:

 

  • A copy of the PI's CV.
  • Head of Department confirmation of the application and the Department has the resources required to undertake the project.

 

The grant application and CV will be assessed by a panel of at least six independent reviewers using a standardised scoring system. Applicants will be informed of the decision one week before the ASA annual scientific meeting "Antimicrobials 2016".

 

Applications will be accepted online from 15 August to 31 October 2016.

 

Click here for the Research Grant Application Form.

 

For further enquiries please contact the ASA secretary on info@asainc.net.au

 
 
2 Aug 2016
Antimicrobials 2017 and StaphPath 2017 Meeting Website
Antimicrobials 2017 and StaphPath 2017 
Adelaide Convention Centre and Intercontinental Hotel
23 - 25 February and 25 - 26 February 2017
 
On behalf of the Australian Society for Antimicrobials (ASA), I invite you to the Society’s 18th Annual Scientific Meeting “Antimicrobials 2017” and to the inaugural “StaphPath 2017” meeting to be held at the Adelaide Convention Centre and the Intercontinental Hotel, Adelaide, on Thursday 23rd – Sunday 26th February 2017.
 
“Antimicrobials 2017” and “StaphPath 2017” will share joint symposia on Saturday 25th February 2017. A discounted “StaphPath 2017” registration fee is available to Antimicrobials 2017 delegates.
 
The ASA are pleased to offer Australian Society for Microbiology (ASM) and Australasian Society for Infectious Diseases (ASID) members, who are non-ASA members, the ASA members registration fee to attend “StaphPath 2017”.
 
Abstract submission and meeting registration is now available on the meeting website www.antimicrobials2017.com 
 
Important Dates
 
Abstract Submission Deadline: Friday, 9 December 2016
 
Abstract Notification: Friday, 16 December 2016
 
Early Bird Registration Deadline: Friday, 6 January 2017
 
Accommodation Booking Deadline: Friday, 20 January 2017
 
The meetings’ programme is available on www.antimicrobials2017.com
 
23 Jun 2016
Advances in Microbial Genomics for Public Health and Clinical Microbiology Symposium
Given the dynamic and dispersed nature of pathogenic microbes and the relentless rise of superbugs that are resistant to almost all classes of antibiotics, preventing and controlling the spread of infectious diseases in humans, in animals, and in our food and water will require timely, effective and high-resolution responses. Genomics is revolutionizing all aspects of microbiology and in forward thinking countries around the world is transforming approaches to controlling the spread of public health and clinical microbiological pathogens. 
 
Doherty Applied Microbial Genomics will be hosting a one-day symposium at the Peter Doherty Institute for Infection & Immunity, entitled “Advances in Microbial Genomics for Public Health and Clinical Microbiology” that will critically examine the impact of microbial genomics on public health and clinical microbiology practice overseas and in Australia, and show how this cutting edge technology is helping protect the public from the threat of infectious diseases.
 
Confirmed speakers include international experts Prof Jennifer Gardy from the British Columbia Centre for Disease Control and Dr Phil Ashton from Public Health England, as well as national experts in the fields of applied microbial genomics, epidemiology and antimicrobial resistance that includes Prof Eddie Holmes from the University of Sydney, Prof Darren Trott from the University of Adelaide, Prof Jodie McVernon from the University of Melbourne and A/ Prof Torsten Seemann the Lead Bioinformatician at Doherty Applied Microbial Genomics.
 
The target audience are researchers, clinicians, epidemiologists, public health professionals and veterinarians.
 
The preliminary program is available to download here
 
WHEN
Tuesday, 15 November 2016 from 8:00 AM to 6:30 PM (AEDT) - Add to Calendar
WHERE
The Peter Doherty Institute for Infection and Immunity - 792 Elizabeth Street, Melbourne, VIC 3000 - View Map
 
 
12 Jun 2016
Preliminary Announcement: Antimicrobials 2017 and StaphPath 2017
On behalf of the Australian Society for Antimicrobials I would like to invite you to the Society’s 18th Annual Scientific Meeting “Antimicrobials 2017” and to the inaugural “StaphPath 2017” to be held at the Adelaide Convention Centre and the Intercontinental Hotel, Adelaide, on Thursday 23rd – Sunday 26th February 2017.
 
“Antimicrobials 2017” and “StaphPath 2017” will share joint symposia on Saturday 25th February 2017. 
 
Antimicrobials 2017 (Thursday 23rd – Saturday 25th February 2017)
 
I am pleased to announce William Hope, The University of Liverpool, UK; Stefan Schwarz, Federal Research Institute for Animal Health, Germany; and Geraint Rogers, Flinders University, South Australia will be participating at the meeting.  William will be presenting the plenary “PK/PD in Everyday Antimicrobial Treatment”, and Stefan will be presenting “One Health Aspects of Antimicrobial Resistance in Gram Negative Bacteria and Enterococci".  Geraint’s plenary will be “Antimicrobial Resistance and the Human Genome”.
 
The 2017 Howard Florey Oration will be delivered by Tim Walsh, Cardiff University, Wales.  
 
The program’s symposia cover many different aspects on antimicrobials and symposium sessions include “Mycology”, “The Cutting Edge: Resistance Detection and Management, “New Frontiers: The Human Resistome and Metagenomics”, “Enterococci”, “Staphylococcal Topics”, “Global MRSA Epidemiology” and “Antibiotic Resistance and Staphylococcal Mobile Genomic Elements”.   In addition, we have two pharmacy symposia on Saturday afternoon titled “System wide Initiatives” and "From Theory to Bedside”.  Six proffered papers and two poster sessions are also planned for the meeting.
 
To celebrate the 100th anniversary of the birth of Howard Florey the “Antimicrobials 2017” registration will include a formal dinner at the Adelaide Town Hall.
 
StaphPath 2017 (Saturday 25th – Sunday 26th February 2017)
 
 
In addition to the “Staphylococcal Topics”, “Global MRSA Epidemiology” and “Antibiotic Resistance and Staphylococcal Mobile Genomic Elements” symposia StaphPath 2017 will have four plenary sessions including “Staphylococcal Virulence: What does WGS tell us” (Ruth Massey, University of Bath, UK), “S. aureus and the Ecology of the Nasal Microbiome (Robert Skov, Statens Serum Institute, Denmark), “What’s new in Staphylococcal Pathogenesis” (Jodi Lindsay, St Georges’ University of London, UK), and “The Emergence of cfr in Human and Animal Staphylococci” (Stefan Schwarz).  Three additional symposia are also scheduled including “ST93 and Beyond”, “Multi-resistant Staphylococci in the Australian Veterinary Setting” and “Novel Anti-staphylococcal Approaches” A poster session is also planned for the meeting.   
 
A discounted registration will be provided for delegates attending both meetings
 
To promote discussion and interaction between delegates and the invited speakers the meetings’ registration will include lunches, morning and afternoon teas.
 
The meetings website which will include registration and abstract submission will be available in July.  
 
I am confident that you will find both meetings’ programs both scientifically stimulating and informative and we look forward to meeting you in Adelaide.
 
Ben Howden
President ASA
 
7 May 2016
17th International Symposium on Staphylococi and Staphylococcal Infections
Dear Colleagues,


We would like to invite you to the 17th International Symposium on Staphylococci and Staphylococcal Infections, to be held in Seoul, South Korea, from August 30 to September 2, 2016

The ISSSI 2016 SEOUL will cover a number of interdisciplinary subjects regarding staphylococci and staphylococcal infections. Sessions will be presented by the world's leading experts in each of the research fields. Oral and poster sessions will be an integral part of the program as well, and all delegates are invited to submit abstracts. We will also offer a lot of travel grants and a range of socializing programs to build solid friendship among the participants.


Sincerely,

ISSSI 2016 SEOUL Organizing Committee

E-mail: office@isssi2016.org 
Official Website: http://www.isssi2016.org
 
7 May 2016
Communicable Diseases Intelligence Volume 40 Supplement April 2016
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Communicable Diseases Intelligence Volume 40 Supplement is now available

Summary of National Surveillance Data on Vaccine Preventable Diseases in Australia, 2008–2011

 
7 May 2016
Communicable Diseases Intelligence Volume 40 Number 1 March 2016
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Communicable Diseases Intelligence Volume 40 Number 1 March 2016

Contents

This issue is available as a full PDF (9.2 MB) or by individual articles below.

Original article

Clinical diagnosis and chemical confirmation of ciguatera fish poisoning in New South Wales, Australia
Hazel Farrell, Anthony Zammit, D Tim Harwood, Paul McNabb, Craig Shadbolt, Jennifer Manning, John A Turahui, Debra J van den Berg, Lisa Szabo 
Full text [HTML] | Full text [PDF 359 KB]

Short report

Infectious and congenital syphilis notifications associated with an ongoing outbreak in northern Australia
Amy Bright, Australian Government Department of Health and Johanna Dups, Western Australian Department of Health, on behalf of the Multijurisdictional Syphilis Outbreak Group
Full text [HTML] | Full text [PDF 320 KB]

Surveillance summaries

Surveillance systems reported in Communicable Diseases Intelligence, 2016
Full text [HTML] | Full text [PDF 2096 KB]

Annual reports

Arboviral diseases and malaria in Australia, 2012–13: Annual report of the National Arbovirus and Malaria Advisory Committee
Katrina E Knope, Nina Kurucz, Stephen L Doggett, Mike Muller, Cheryl A Johansen, Rebecca Feldman, Michaela Hobby, Sonya Bennett, Angus Sly, Stacey Lynch, Bart J Currie, Jay Nicholson, and the National Arbovirus and Malaria Advisory Committee
Full text [HTML] | Full text [PDF 1.4 MB]
Australia’s notifiable disease status, 2014: Annual report of the National Notifiable Diseases Surveillance System
NNDSS Annual Report Working Group 
Full text [HTML] | Full text [PDF 5.4 MB]
Immunisation coverage annual report, 2013
Brynley P Hull, Aditi Dey, Frank H Beard, Robert I Menzies, Julia M Brotherton, Peter B McIntyre 
Full text [HTML] | Full text [PDF 1.7 MB]

Quarterly reports

National Notifiable Diseases Surveillance System, 1 October to 31 December 2015
Full text [HTML] | Full text [PDF 479 KB]
Australian childhood immunisation coverage, 1 July to 30 June cohort, assessed as at 30 September 2015 
Alexandra Hendry for the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases
Full text [HTML] | Full text [PDF 230 KB]
Australian Gonococcal Surveillance Programme, 1 July to 30 September 2015
Monica M Lahra, Rodney P Enriquez, The Prince of Wales Hospital, Randwick, for The National Neisseria Network 
Full text [HTML] | Full text [PDF 253 MB]
Australian Sentinel Practices Research Network, 1 October to 31 December 2015
Monique B-N Chilver, Daniel Blakeley, Nigel P Stocks for the Australian Sentinel Practices Research Network 
Full text [HTML] | Full text [PDF 287 KB]
Invasive pneumococcal disease surveillance Australia, 1 October to 31 December 2015 
Rachel de Kluyver, Cindy Toms and the Enhanced Invasive Pneumococcal Disease Surveillance Working Group, for the Communicable Diseases Network Australia 
Full text [HTML] | Full text [PDF 3857 KB]

Administration

Communicable Diseases Intelligence instructions for authors
Full text [HTML] | Full text [PDF 193 KB]

Editor: Margaret Curran
Deputy Editor: Katrina Knope 
Associate Editors: Timothy Sloan-Gardner 
Editorial and Production Staff: Alison Milton
ISSN 1445-4866 Online

Disclaimer

Opinions expressed in Communicable Diseases Intelligence are those of the authors and not necessarily those of the Australian Government Department of Health or the Communicable Diseases Network Australia. Data may be subject to revision.
 
21 Mar 2016
2016 ASA Foundation Members
The Australian Society for Antimicrobials wishes to acknowledge the following companies for becoming Foundation (Sustaining) Members of the Society
 
10 Jan 2016
Antimicrobials 2016: ASA Travel Awards
On behalf of the ASA Committee I would like to congratulate the following ASA members for being awarded an ASA travel grant to attend Antimicrobials 2016:
 
Resolving the enigma of methicillin-resistance transfer in Staphylococcus aureus
J. Ramsay, Curtin University 
 
Zoonotic transmission of the methicillin-resistant Staphylococcus aureus ST612-IV equine strain
E. Raby, Fiona Stanley Hospital
 
The vancomycin LECOFF and vanB subtypes of E. faecium isolated in Australia
T. Lee, Murdoch University
 
Each awarded has been provided with a complementary ASA registration, return economy airfares and a three day per diem
 
7 Jun 2015
Australian National Antimicrobial Resistance Strategy
The Australian National Antimicrobial Resistance Strategy has been released by the Minister for Health and Sport and the Minister for Agriculture. A copy of the strategy is available at the following links:
 
 
The Australian Society for Antimicrobials is a member of the Australian Strategic and Technical Advisory Group on Antimicrobial Resistance (ASTAG) and has been heavily engaged in the development of this national strategy.